{"ticker": {"uuid": "f715f74c-b258-4cc2-9c0f-00617f889540", "symbol": "BIIB", "name": "Biogen Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation", "summary": "Investing.com -- Wolfe Research upgraded two major pharmaceutical companies to Outperform on Thursday, citing stronger growth prospects, attractive valuations and a series of upcoming clinical catalysts. For Biogen, Wolfe raised its rating from Peer Perform and set a $300 price target, arguing that the company's late-stage pipeline offers significant upside that is not fully reflected in current valuations. The firm highlighted litifilimab and felzartamab as key assets, with clinical readouts expected over the coming year. Wolfe said litifilimab could become the first biologic approved for cut", "url": "https://finance.yahoo.com/healthcare/articles/wolfe-research-upgrades-biogen-abbvie-135201210.html", "source_link": "https://finance.yahoo.com/healthcare/articles/wolfe-research-upgrades-biogen-abbvie-135201210.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-13T13:52:01+00:00", "published_display": "13 Aug 2026 13:52", "source_kind": "aggregator", "sentiment": "positive", "sentiment_pct": 79, "tone_signals": ["Operating growth", "Growth forecast", "Positive valuation view"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.211565, "evidence_share": 32.4, "evidence_share_display": "32.4", "freshness_pct": 95.9, "age_days": 0.2, "influence_label": "High", "duplicate_count": 3, "topics": ["Balance Sheet", "Clinical Trials", "Earnings", "Earnings Growth", "Pharma", "Price Target"], "evidence_basis": "", "score_included": true}, {"title": "NovelMed Advances NM5072 for Multiple Ocular Disorders", "summary": "NovelMed Therapeutics Inc Key Highlights Multi-indication precedent: Biogen's approximately $5.6 billion acquisition of Apellis added EMPAVELI for PNH and SYFOVRE for GA, both of which contain pegcetacoplan. Primate proof of concept: A single intravitreal dose of NM5072 reduced CNV, hemorrhage, and retinal fibrosis in a rhesus monkey model. Phase I clinical experience: NM5072 completed a Phase I study in 48 healthy volunteers and received FDA Orphan Drug Designation for PNH. Potential extended durability: Rabbit PK/PD data estimated an ocular half-life of seven days. Translational modeling pro", "url": "https://finance.yahoo.com/healthcare/articles/novelmed-advances-nm5072-multiple-ocular-192700904.html", "source_link": "https://finance.yahoo.com/healthcare/articles/novelmed-advances-nm5072-multiple-ocular-192700904.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-11T19:27:00+00:00", "published_display": "11 Aug 2026 19:27", "source_kind": "aggregator", "sentiment": "neutral", "sentiment_pct": 56, "tone_signals": [], "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.073308, "evidence_share": 11.2, "evidence_share_display": "11.2", "freshness_pct": 82.5, "age_days": 1.9, "influence_label": "Medium", "duplicate_count": 5, "topics": [], "evidence_basis": "", "score_included": true}, {"title": "The Galien Foundation Announces 2026 Prix Galien USA Nominees for \"Best Biotechnology Product,\" \"Best Pharmaceutical Product,\" and \"Best Product for Rare/Orphan Diseases\"", "summary": "A Milestone 20th Anniversary Edition Recognizing Excellence in Medical Science and Patient Care NEW YORK, Aug. 11, 2026 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the nominees for the 2026 Prix Galien USA Awards in the \"Best Biotechnology Product,\" \"Best Pharmaceutical Product,\" and \"Best Product for Rare/Orphan Diseases\" categories. Winners will be honored at the Prix Galien USA Awards Ceremony on October 29, 2026, at the American Museum of Natural History in New York City.logo \"We are proud to recog", "url": "https://finance.yahoo.com/healthcare/articles/galien-foundation-announces-2026-prix-130000242.html", "source_link": "https://finance.yahoo.com/healthcare/articles/galien-foundation-announces-2026-prix-130000242.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-11T13:00:00+00:00", "published_display": "11 Aug 2026 13:00", "source_kind": "aggregator", "sentiment": "positive", "sentiment_pct": 62, "tone_signals": ["Positive financial language"], "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.117674, "evidence_share": 18.0, "evidence_share_display": "18", "freshness_pct": 80.3, "age_days": 2.2, "influence_label": "Medium", "duplicate_count": 5, "topics": ["BIOTECH", "Biotech", "FDA-APPROVAL", "Fda Approval", "PHARMACEUTICALS", "Pharmaceuticals"], "evidence_basis": "", "score_included": true}, {"title": "HSBC Adjusts Price Target on Biogen to $165 From $157, Keeps Reduce Rating", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22HSBC+Adjusts+Price+Target+on+Biogen+to+%24165+From+%24157%2C+Keeps+Reduce+Rating%22+%22www.marketscreener.com%22", "source_link_is_lookup": true, "source_name": "www.marketscreener.com", "published_at": "2026-08-10T12:57:34+00:00", "published_display": "10 Aug 2026 12:57", "source_kind": "publisher", "sentiment": "negative", "sentiment_pct": 43, "tone_signals": ["Negative financial language"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.043387, "evidence_share": 6.6, "evidence_share_display": "6.6", "freshness_pct": 47.5, "age_days": 3.2, "influence_label": "Low", "duplicate_count": 4, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen (BIIB) Q2 2026 Earnings Call Transcript", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+%28BIIB%29+Q2+2026+Earnings+Call+Transcript%22+%22Motley+Fool%22", "source_link_is_lookup": true, "source_name": "Motley Fool", "published_at": "2026-08-08T00:02:43+00:00", "published_display": "08 Aug 2026 00:02", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.037042, "evidence_share": 5.7, "evidence_share_display": "5.7", "freshness_pct": 45.0, "age_days": 5.8, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum", "summary": "Denali Therapeutics DNLI reported a second-quarter 2026 loss of 68 cents per share, narrower than the Zacks Consensus Estimate of a loss of 73 cents. The company incurred a loss of 72 cents in the year-ago quarter. In late March, Denali secured a major regulatory win with the FDA approval of its lead pipeline candidate tividenofusp alfa-eknm, under the brand name Avlayah, for the treatment of Hunter Syndrome (MPS II). The FDA granted accelerated approval to Avlayah, marking the first new treatment option in nearly 20 years for patients with Hunter syndrome, a rare lysosomal storage disorder. I", "url": "https://finance.yahoo.com/healthcare/articles/dnli-q2-loss-narrows-avlayah-183100129.html", "source_link": "https://finance.yahoo.com/healthcare/articles/dnli-q2-loss-narrows-avlayah-183100129.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:31:00+00:00", "published_display": "07 Aug 2026 18:31", "source_kind": "aggregator", "sentiment": "positive", "sentiment_pct": 70, "tone_signals": ["Beat expectations", "Contract or approval won", "Loss narrowed"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.097742, "evidence_share": 15.0, "evidence_share_display": "15", "freshness_pct": 43.6, "age_days": 6.0, "influence_label": "Medium", "duplicate_count": 5, "topics": ["BIOTECH", "Biotech", "CLINICAL-TRIALS", "Clinical Trials", "EARNINGS", "Earnings"], "evidence_basis": "", "score_included": true}, {"title": "Lloyd Minor (BIIB) files Form 144 for 593-share NASDAQ stock sale", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Lloyd+Minor+%28BIIB%29+files+Form+144+for+593-share+NASDAQ+stock+sale%22+%22Stock+Titan%22", "source_link_is_lookup": true, "source_name": "Stock Titan", "published_at": "2026-08-04T23:57:37.264461+00:00", "published_display": "04 Aug 2026 23:57", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002569, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 4.8, "age_days": 8.8, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Form 144 BIOGEN INC. For: 3 August By Investing.com", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Form+144+BIOGEN+INC.+For%3A+3+August+By+Investing.com%22+%22Investing.com+Canada%22", "source_link_is_lookup": true, "source_name": "Investing.com Canada", "published_at": "2026-08-03T23:10:04.830191+00:00", "published_display": "03 Aug 2026 23:10", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002454, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 3.4, "age_days": 9.8, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen Inc. stock underperforms Friday when compared to competitors", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+Inc.+stock+underperforms+Friday+when+compared+to+competitors%22+%22MarketWatch%22", "source_link_is_lookup": true, "source_name": "MarketWatch", "published_at": "2026-08-02T10:58:53.967688+00:00", "published_display": "02 Aug 2026 10:58", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001455, "evidence_share": 0.2, "evidence_share_display": "0.2", "freshness_pct": 2.0, "age_days": 11.3, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Why Biogen (BIIB) Is Up 5.8% After Q2 Revenue Beat And Raised 2026 Guidance - And What's Next", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Why+Biogen+%28BIIB%29+Is+Up+5.8%25+After+Q2+Revenue+Beat+And+Raised+2026+Guidance+-+And+What%27s+Next%22+%22Simply+Wall+St%22", "source_link_is_lookup": true, "source_name": "Simply Wall St", "published_at": "2026-07-31T05:33:11.978674+00:00", "published_display": "31 Jul 2026 05:33", "source_kind": "publisher", "sentiment": "positive", "sentiment_pct": 75, "tone_signals": ["Beat expectations"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.032773, "evidence_share": 5.0, "evidence_share_display": "5", "freshness_pct": 15.3, "age_days": 13.5, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "BMO Capital Adjusts Price Target on Biogen to $208 From $196, Maintains Market Perform Rating", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22BMO+Capital+Adjusts+Price+Target+on+Biogen+to+%24208+From+%24196%2C+Maintains+Market+Perform+Rating%22+%22MT+Newswires%22", "source_link_is_lookup": true, "source_name": "MT Newswires", "published_at": "2026-07-30T16:06:20.401906+00:00", "published_display": "30 Jul 2026 16:06", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00254, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 3.9, "age_days": 14.1, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Earnings Flash (BIIB) Biogen Posts Q2 Total Revenue $2.74B, vs. FactSet Est of $2.46B", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Earnings+Flash+%28BIIB%29+Biogen+Posts+Q2+Total+Revenue+%242.74B%2C+vs.+FactSet+Est+of+%242.46B%22+%22marketscreener.com%22", "source_link_is_lookup": true, "source_name": "marketscreener.com", "published_at": "2026-07-29T12:07:03.362275+00:00", "published_display": "29 Jul 2026 12:07", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.009929, "evidence_share": 1.5, "evidence_share_display": "1.5", "freshness_pct": 12.1, "age_days": 15.3, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Can These 5 Biotech Stocks Beat Wall Street's Q2 Estimates?", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Can+These+5+Biotech+Stocks+Beat+Wall+Street%27s+Q2+Estimates%3F%22+%22TradingView%22", "source_link_is_lookup": true, "source_name": "TradingView", "published_at": "2026-07-29T07:44:47.122224+00:00", "published_display": "29 Jul 2026 07:44", "source_kind": "publisher", "sentiment": "positive", "sentiment_pct": 75, "tone_signals": ["Beat expectations"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00066, "evidence_share": 0.1, "evidence_share_display": "0.1", "freshness_pct": 0.5, "age_days": 15.4, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of Earnings", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+%28BIIB%29+Reports+Q2%3A+Everything+You+Need+To+Know+Ahead+Of+Earnings%22+%22The+Globe+and+Mail%22", "source_link_is_lookup": true, "source_name": "The Globe and Mail", "published_at": "2026-07-28T06:44:01.870361+00:00", "published_display": "28 Jul 2026 06:44", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.008379, "evidence_share": 1.3, "evidence_share_display": "1.3", "freshness_pct": 10.2, "age_days": 16.5, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen Q2 Earnings: Can New Drugs Counter Falling MS Sales?", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+Q2+Earnings%3A+Can+New+Drugs+Counter+Falling+MS+Sales%3F%22+%22TradingView%22", "source_link_is_lookup": true, "source_name": "TradingView", "published_at": "2026-07-25T07:13:35.971054+00:00", "published_display": "25 Jul 2026 07:13", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.005544, "evidence_share": 0.8, "evidence_share_display": "0.8", "freshness_pct": 6.7, "age_days": 19.5, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "At-Home LEQEMBI Autoinjector And New Tau Data Might Change The Case For Investing In Biogen (BIIB)", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22At-Home+LEQEMBI+Autoinjector+And+New+Tau+Data+Might+Change+The+Case+For+Investing+In+Biogen+%28BIIB%29%22+%22Simply+Wall+Street%22", "source_link_is_lookup": true, "source_name": "Simply Wall Street", "published_at": "2026-07-23T20:13:36.008605+00:00", "published_display": "23 Jul 2026 20:13", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 3.8e-05, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.1, "age_days": 20.9, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Analysts+Estimate+Biogen+Inc.+%28BIIB%29+to+Report+a+Decline+in+Earnings%3A+What+to+Look+Out+for%22+%22Zacks%22", "source_link_is_lookup": true, "source_name": "Zacks", "published_at": "2026-07-22T18:07:34.741210+00:00", "published_display": "22 Jul 2026 18:07", "source_kind": "publisher", "sentiment": "negative", "sentiment_pct": 43, "tone_signals": ["Negative financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006301, "evidence_share": 1.0, "evidence_share_display": "1", "freshness_pct": 4.7, "age_days": 22.0, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Goldman Sachs Adjusts Price Target on Biogen to $271 From $250, Maintains Buy Rating", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Goldman+Sachs+Adjusts+Price+Target+on+Biogen+to+%24271+From+%24250%2C+Maintains+Buy+Rating%22+%22MT+Newswires%22", "source_link_is_lookup": true, "source_name": "MT Newswires", "published_at": "2026-07-20T13:13:55.955892+00:00", "published_display": "20 Jul 2026 13:13", "source_kind": "publisher", "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000245, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.4, "age_days": 24.2, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen Inc. stock outperforms competitors on strong trading day", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+Inc.+stock+outperforms+competitors+on+strong+trading+day%22+%22MarketWatch%22", "source_link_is_lookup": true, "source_name": "MarketWatch", "published_at": "2026-07-17T17:31:30.344464+00:00", "published_display": "17 Jul 2026 17:31", "source_kind": "publisher", "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 9e-06, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.0, "age_days": 27.0, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}], "by_tier": {"direct": [{"title": "Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation", "summary": "Investing.com -- Wolfe Research upgraded two major pharmaceutical companies to Outperform on Thursday, citing stronger growth prospects, attractive valuations and a series of upcoming clinical catalysts. For Biogen, Wolfe raised its rating from Peer Perform and set a $300 price target, arguing that the company's late-stage pipeline offers significant upside that is not fully reflected in current valuations. The firm highlighted litifilimab and felzartamab as key assets, with clinical readouts expected over the coming year. Wolfe said litifilimab could become the first biologic approved for cut", "url": "https://finance.yahoo.com/healthcare/articles/wolfe-research-upgrades-biogen-abbvie-135201210.html", "source_link": "https://finance.yahoo.com/healthcare/articles/wolfe-research-upgrades-biogen-abbvie-135201210.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-13T13:52:01+00:00", "published_display": "13 Aug 2026 13:52", "provider": "eodhd", "providers": ["eodhd"], "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "f3fab633d584d08932a2870ce562c4f22cbee989985bd7c4a16774be1769ba11", "target_scope": "", "durable_archive": false, "archive_provider": "", "sentiment_origin": "provider_blend", "model_confidence": 0.782, "provider_directional_mass": 0.164, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.187, "sentiment": "positive", "sentiment_pct": 79, "tone_signals": ["Operating growth", "Growth forecast", "Positive valuation view"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.211565, "evidence_share": 32.4, "evidence_share_display": "32.4", "freshness_pct": 95.9, "age_days": 0.2, "influence_label": "High", "duplicate_count": 3, "topics": ["Balance Sheet", "Clinical Trials", "Earnings", "Earnings Growth", "Pharma", "Price Target"], "evidence_basis": "", "score_included": true}, {"title": "NovelMed Advances NM5072 for Multiple Ocular Disorders", "summary": "NovelMed Therapeutics Inc Key Highlights Multi-indication precedent: Biogen's approximately $5.6 billion acquisition of Apellis added EMPAVELI for PNH and SYFOVRE for GA, both of which contain pegcetacoplan. Primate proof of concept: A single intravitreal dose of NM5072 reduced CNV, hemorrhage, and retinal fibrosis in a rhesus monkey model. Phase I clinical experience: NM5072 completed a Phase I study in 48 healthy volunteers and received FDA Orphan Drug Designation for PNH. Potential extended durability: Rabbit PK/PD data estimated an ocular half-life of seven days. Translational modeling pro", "url": "https://finance.yahoo.com/healthcare/articles/novelmed-advances-nm5072-multiple-ocular-192700904.html", "source_link": "https://finance.yahoo.com/healthcare/articles/novelmed-advances-nm5072-multiple-ocular-192700904.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-11T19:27:00+00:00", "published_display": "11 Aug 2026 19:27", "provider": "eodhd", "providers": ["eodhd"], "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "662045fab58afd12d39202fb4b73b01ddf3d851fe5ff4d19fa66e5567a78b418", "target_scope": "", "durable_archive": false, "archive_provider": "", "sentiment_origin": "provider_blend", "model_confidence": 0.444, "provider_directional_mass": 0.0781, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 56, "tone_signals": [], "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.073308, "evidence_share": 11.2, "evidence_share_display": "11.2", "freshness_pct": 82.5, "age_days": 1.9, "influence_label": "Medium", "duplicate_count": 5, "topics": [], "evidence_basis": "", "score_included": true}, {"title": "The Galien Foundation Announces 2026 Prix Galien USA Nominees for \"Best Biotechnology Product,\" \"Best Pharmaceutical Product,\" and \"Best Product for Rare/Orphan Diseases\"", "summary": "A Milestone 20th Anniversary Edition Recognizing Excellence in Medical Science and Patient Care NEW YORK, Aug. 11, 2026 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the nominees for the 2026 Prix Galien USA Awards in the \"Best Biotechnology Product,\" \"Best Pharmaceutical Product,\" and \"Best Product for Rare/Orphan Diseases\" categories. Winners will be honored at the Prix Galien USA Awards Ceremony on October 29, 2026, at the American Museum of Natural History in New York City.logo \"We are proud to recog", "url": "https://finance.yahoo.com/healthcare/articles/galien-foundation-announces-2026-prix-130000242.html", "source_link": "https://finance.yahoo.com/healthcare/articles/galien-foundation-announces-2026-prix-130000242.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-11T13:00:00+00:00", "published_display": "11 Aug 2026 13:00", "provider": "eodhd", "providers": ["eodhd"], "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "52566e8435df13cf73fa9717888920ac2672a0bb56e76834a3490f915476fab8", "target_scope": "", "durable_archive": false, "archive_provider": "", "sentiment_origin": "provider_blend", "model_confidence": 0.497, "provider_directional_mass": 0.156, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 62, "tone_signals": ["Positive financial language"], "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.117674, "evidence_share": 18.0, "evidence_share_display": "18", "freshness_pct": 80.3, "age_days": 2.2, "influence_label": "Medium", "duplicate_count": 5, "topics": ["BIOTECH", "Biotech", "FDA-APPROVAL", "Fda Approval", "PHARMACEUTICALS", "Pharmaceuticals"], "evidence_basis": "", "score_included": true}, {"title": "HSBC Adjusts Price Target on Biogen to $165 From $157, Keeps Reduce Rating", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22HSBC+Adjusts+Price+Target+on+Biogen+to+%24165+From+%24157%2C+Keeps+Reduce+Rating%22+%22www.marketscreener.com%22", "source_link_is_lookup": true, "source_name": "www.marketscreener.com", "published_at": "2026-08-10T12:57:34+00:00", "published_display": "10 Aug 2026 12:57", "provider": "archive", "providers": ["archive"], "source_names": ["www.marketscreener.com"], "source_kind": "publisher", "story_key": "5bcd23ab4b2eb9affbfe693c5999b0f70858376632dc46c66f06512a37614ffb", "target_scope": "", "durable_archive": false, "archive_provider": "archive", "sentiment_origin": "stored_reclassified", "model_confidence": 0.461, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "negative", "sentiment_pct": 43, "tone_signals": ["Negative financial language"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.043387, "evidence_share": 6.6, "evidence_share_display": "6.6", "freshness_pct": 47.5, "age_days": 3.2, "influence_label": "Low", "duplicate_count": 4, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen (BIIB) Q2 2026 Earnings Call Transcript", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+%28BIIB%29+Q2+2026+Earnings+Call+Transcript%22+%22Motley+Fool%22", "source_link_is_lookup": true, "source_name": "Motley Fool", "published_at": "2026-08-08T00:02:43+00:00", "published_display": "08 Aug 2026 00:02", "provider": "archive", "providers": ["archive"], "source_names": ["Motley Fool"], "source_kind": "publisher", "story_key": "c11043df18fc2db204f8496ee06727fb7c2686c7bc52d71978e5c5b8fce0d615", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.037042, "evidence_share": 5.7, "evidence_share_display": "5.7", "freshness_pct": 45.0, "age_days": 5.8, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum", "summary": "Denali Therapeutics DNLI reported a second-quarter 2026 loss of 68 cents per share, narrower than the Zacks Consensus Estimate of a loss of 73 cents. The company incurred a loss of 72 cents in the year-ago quarter. In late March, Denali secured a major regulatory win with the FDA approval of its lead pipeline candidate tividenofusp alfa-eknm, under the brand name Avlayah, for the treatment of Hunter Syndrome (MPS II). The FDA granted accelerated approval to Avlayah, marking the first new treatment option in nearly 20 years for patients with Hunter syndrome, a rare lysosomal storage disorder. I", "url": "https://finance.yahoo.com/healthcare/articles/dnli-q2-loss-narrows-avlayah-183100129.html", "source_link": "https://finance.yahoo.com/healthcare/articles/dnli-q2-loss-narrows-avlayah-183100129.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:31:00+00:00", "published_display": "07 Aug 2026 18:31", "provider": "eodhd", "providers": ["eodhd"], "source_names": ["finance.yahoo.com"], "source_kind": "aggregator", "story_key": "71b3f357b34fe62720605e242a88d83e80db1f84b99f4be3c7270a96cfcdfde6", "target_scope": "", "durable_archive": false, "archive_provider": "", "sentiment_origin": "provider_blend", "model_confidence": 0.743, "provider_directional_mass": 0.16, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.507, "sentiment": "positive", "sentiment_pct": 70, "tone_signals": ["Beat expectations", "Contract or approval won", "Loss narrowed"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.097742, "evidence_share": 15.0, "evidence_share_display": "15", "freshness_pct": 43.6, "age_days": 6.0, "influence_label": "Medium", "duplicate_count": 5, "topics": ["BIOTECH", "Biotech", "CLINICAL-TRIALS", "Clinical Trials", "EARNINGS", "Earnings"], "evidence_basis": "", "score_included": true}, {"title": "Lloyd Minor (BIIB) files Form 144 for 593-share NASDAQ stock sale", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Lloyd+Minor+%28BIIB%29+files+Form+144+for+593-share+NASDAQ+stock+sale%22+%22Stock+Titan%22", "source_link_is_lookup": true, "source_name": "Stock Titan", "published_at": "2026-08-04T23:57:37.264461+00:00", "published_display": "04 Aug 2026 23:57", "provider": "archive", "providers": ["archive"], "source_names": ["Stock Titan"], "source_kind": "publisher", "story_key": "acf5cabb837541a8c068bb5f4239294ed8bd5dc76093177ebf6644134c6187c4", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002569, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 4.8, "age_days": 8.8, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Form 144 BIOGEN INC. For: 3 August By Investing.com", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Form+144+BIOGEN+INC.+For%3A+3+August+By+Investing.com%22+%22Investing.com+Canada%22", "source_link_is_lookup": true, "source_name": "Investing.com Canada", "published_at": "2026-08-03T23:10:04.830191+00:00", "published_display": "03 Aug 2026 23:10", "provider": "archive", "providers": ["archive"], "source_names": ["Investing.com Canada"], "source_kind": "publisher", "story_key": "b997298f356e5d95c0856aa2d3203cef6d16f3a356d306add2cdc5250b51ac02", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.002454, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 3.4, "age_days": 9.8, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen Inc. stock underperforms Friday when compared to competitors", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+Inc.+stock+underperforms+Friday+when+compared+to+competitors%22+%22MarketWatch%22", "source_link_is_lookup": true, "source_name": "MarketWatch", "published_at": "2026-08-02T10:58:53.967688+00:00", "published_display": "02 Aug 2026 10:58", "provider": "archive", "providers": ["archive"], "source_names": ["MarketWatch"], "source_kind": "publisher", "story_key": "276426383b8985b27dee7ece11348d3f1150c1c6ecac51807f9839387d150f6d", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.001455, "evidence_share": 0.2, "evidence_share_display": "0.2", "freshness_pct": 2.0, "age_days": 11.3, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Why Biogen (BIIB) Is Up 5.8% After Q2 Revenue Beat And Raised 2026 Guidance - And What's Next", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Why+Biogen+%28BIIB%29+Is+Up+5.8%25+After+Q2+Revenue+Beat+And+Raised+2026+Guidance+-+And+What%27s+Next%22+%22Simply+Wall+St%22", "source_link_is_lookup": true, "source_name": "Simply Wall St", "published_at": "2026-07-31T05:33:11.978674+00:00", "published_display": "31 Jul 2026 05:33", "provider": "archive", "providers": ["archive"], "source_names": ["Simply Wall St"], "source_kind": "publisher", "story_key": "8e9e373b1a1d79312382595e672e5469eb0e94e864b8cecafe77343f6b7b90a1", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.59, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 75, "tone_signals": ["Beat expectations"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.032773, "evidence_share": 5.0, "evidence_share_display": "5", "freshness_pct": 15.3, "age_days": 13.5, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "BMO Capital Adjusts Price Target on Biogen to $208 From $196, Maintains Market Perform Rating", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22BMO+Capital+Adjusts+Price+Target+on+Biogen+to+%24208+From+%24196%2C+Maintains+Market+Perform+Rating%22+%22MT+Newswires%22", "source_link_is_lookup": true, "source_name": "MT Newswires", "published_at": "2026-07-30T16:06:20.401906+00:00", "published_display": "30 Jul 2026 16:06", "provider": "archive", "providers": ["archive"], "source_names": ["MT Newswires"], "source_kind": "publisher", "story_key": "402e0954ced801df3c81f8224abd8b3655389ac5240bc2c6467e0b9c21cf86ba", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00254, "evidence_share": 0.4, "evidence_share_display": "0.4", "freshness_pct": 3.9, "age_days": 14.1, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Earnings Flash (BIIB) Biogen Posts Q2 Total Revenue $2.74B, vs. FactSet Est of $2.46B", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Earnings+Flash+%28BIIB%29+Biogen+Posts+Q2+Total+Revenue+%242.74B%2C+vs.+FactSet+Est+of+%242.46B%22+%22marketscreener.com%22", "source_link_is_lookup": true, "source_name": "marketscreener.com", "published_at": "2026-07-29T12:07:03.362275+00:00", "published_display": "29 Jul 2026 12:07", "provider": "archive", "providers": ["archive"], "source_names": ["marketscreener.com"], "source_kind": "publisher", "story_key": "f0b6c4d949bbb8ca41cb0480e443d2be5434772645ad1696ff3288cecbb8b56f", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.009929, "evidence_share": 1.5, "evidence_share_display": "1.5", "freshness_pct": 12.1, "age_days": 15.3, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Can These 5 Biotech Stocks Beat Wall Street's Q2 Estimates?", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Can+These+5+Biotech+Stocks+Beat+Wall+Street%27s+Q2+Estimates%3F%22+%22TradingView%22", "source_link_is_lookup": true, "source_name": "TradingView", "published_at": "2026-07-29T07:44:47.122224+00:00", "published_display": "29 Jul 2026 07:44", "provider": "archive", "providers": ["archive"], "source_names": ["TradingView"], "source_kind": "publisher", "story_key": "f27c86cb32980b57ef76f6bbabef48497b7b5cffbf78332d8b656728a6a67f7a", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.59, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 75, "tone_signals": ["Beat expectations"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.00066, "evidence_share": 0.1, "evidence_share_display": "0.1", "freshness_pct": 0.5, "age_days": 15.4, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of Earnings", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+%28BIIB%29+Reports+Q2%3A+Everything+You+Need+To+Know+Ahead+Of+Earnings%22+%22The+Globe+and+Mail%22", "source_link_is_lookup": true, "source_name": "The Globe and Mail", "published_at": "2026-07-28T06:44:01.870361+00:00", "published_display": "28 Jul 2026 06:44", "provider": "archive", "providers": ["archive"], "source_names": ["The Globe and Mail"], "source_kind": "publisher", "story_key": "2bbb5f3f4ffc461aa41aed709a94923db854c10d294d6fa1d29bc925a8b220ad", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.008379, "evidence_share": 1.3, "evidence_share_display": "1.3", "freshness_pct": 10.2, "age_days": 16.5, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen Q2 Earnings: Can New Drugs Counter Falling MS Sales?", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+Q2+Earnings%3A+Can+New+Drugs+Counter+Falling+MS+Sales%3F%22+%22TradingView%22", "source_link_is_lookup": true, "source_name": "TradingView", "published_at": "2026-07-25T07:13:35.971054+00:00", "published_display": "25 Jul 2026 07:13", "provider": "archive", "providers": ["archive"], "source_names": ["TradingView"], "source_kind": "publisher", "story_key": "a6de8799c4533d71d45ac8bb187d73c44a2b269b1b02df18fe9e57f6e53d9868", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.005544, "evidence_share": 0.8, "evidence_share_display": "0.8", "freshness_pct": 6.7, "age_days": 19.5, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "At-Home LEQEMBI Autoinjector And New Tau Data Might Change The Case For Investing In Biogen (BIIB)", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22At-Home+LEQEMBI+Autoinjector+And+New+Tau+Data+Might+Change+The+Case+For+Investing+In+Biogen+%28BIIB%29%22+%22Simply+Wall+Street%22", "source_link_is_lookup": true, "source_name": "Simply Wall Street", "published_at": "2026-07-23T20:13:36.008605+00:00", "published_display": "23 Jul 2026 20:13", "provider": "archive", "providers": ["archive"], "source_names": ["Simply Wall Street"], "source_kind": "publisher", "story_key": "183160ed675d2c8f9c8123ca0c70def9cb78222494a4e5021bf9e8376db85d08", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 3.8e-05, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.1, "age_days": 20.9, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Analysts+Estimate+Biogen+Inc.+%28BIIB%29+to+Report+a+Decline+in+Earnings%3A+What+to+Look+Out+for%22+%22Zacks%22", "source_link_is_lookup": true, "source_name": "Zacks", "published_at": "2026-07-22T18:07:34.741210+00:00", "published_display": "22 Jul 2026 18:07", "provider": "archive", "providers": ["archive"], "source_names": ["Zacks"], "source_kind": "publisher", "story_key": "3b949c80da13bc7f9fe161a34b03895f2c715427bf007f1f168700d7fe83ed35", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.461, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "negative", "sentiment_pct": 43, "tone_signals": ["Negative financial language"], "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.006301, "evidence_share": 1.0, "evidence_share_display": "1", "freshness_pct": 4.7, "age_days": 22.0, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Goldman Sachs Adjusts Price Target on Biogen to $271 From $250, Maintains Buy Rating", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Goldman+Sachs+Adjusts+Price+Target+on+Biogen+to+%24271+From+%24250%2C+Maintains+Buy+Rating%22+%22MT+Newswires%22", "source_link_is_lookup": true, "source_name": "MT Newswires", "published_at": "2026-07-20T13:13:55.955892+00:00", "published_display": "20 Jul 2026 13:13", "provider": "archive", "providers": ["archive"], "source_names": ["MT Newswires"], "source_kind": "publisher", "story_key": "638c90a95ad72d0197fb8011a18f7013e39b4732734ec6beddd7b9e3959238b0", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.4, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "neutral", "sentiment_pct": 50, "tone_signals": [], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.000245, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.4, "age_days": 24.2, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}, {"title": "Biogen Inc. stock outperforms competitors on strong trading day", "summary": "", "url": "", "source_link": "https://www.google.com/search?tbm=nws&q=%22Biogen+Inc.+stock+outperforms+competitors+on+strong+trading+day%22+%22MarketWatch%22", "source_link_is_lookup": true, "source_name": "MarketWatch", "published_at": "2026-07-17T17:31:30.344464+00:00", "published_display": "17 Jul 2026 17:31", "provider": "archive", "providers": ["archive"], "source_names": ["MarketWatch"], "source_kind": "publisher", "story_key": "d01a663d2018077829f65ffbba881904abcfcf490660dde6c43286f8fbd9383e", "target_scope": "", "durable_archive": true, "archive_provider": "snapshot", "sentiment_origin": "stored_reclassified", "model_confidence": 0.461, "provider_directional_mass": null, "relevance_score": 0.78, "entity_mapped": true, "sentiment_conflict": 0.0, "sentiment": "positive", "sentiment_pct": 57, "tone_signals": ["Positive financial language"], "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 9e-06, "evidence_share": 0.0, "evidence_share_display": "<0.1", "freshness_pct": 0.0, "age_days": 27.0, "influence_label": "Low", "duplicate_count": 2, "topics": [], "evidence_basis": "headline_only", "score_included": true}], "industry": [], "sector": []}, "total_fetched": 19, "total_unique": 19, "total_relevant": 19, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 4}, "raw_articles": 23, "unique_stories": 19, "duplicates_removed": 4, "relevant_stories": 19, "matched_archive_stories": 19, "current_evidence": 19, "direct_evidence": 19, "eodhd_articles": 4, "archive_articles": 15, "eodhd": {"configured": true, "status": "healthy", "calls_used": 450, "call_budget": 500, "budget_used_pct": 90.0, "requests_made": 90, "last_success_at": "2026-08-13T18:01:20.695134+00:00", "newest_seen_at": "2026-08-13T17:51:50+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3123, "unmapped_mentions": 1847}, "status": "healthy", "durable_evidence_used": true, "durable_collected_at": "2026-08-13T14:35:51.402860+00:00", "durable_newest_article_at": "2026-08-13T13:52:01+00:00", "durable_story_count": 19}, "sentiment_summary": {"positive": 6, "negative": 2, "neutral": 11, "score": 57, "raw_score": 66, "total": 19, "evidence_count": 19, "effective_articles": 5.47, "information_mass": 0.654, "direct_story_count": 19, "direct_source_count": 13, "industry_story_count": 0, "sector_story_count": 0, "story_count": 19, "source_count": 13, "source_concentration": 0.5966, "direct_share": 100, "dispersion": 12, "confidence": 36, "evidence_status": "provisional", "score_version": "evidence-v7", "window_days": 30, "weighting_method": "event-aware exponential freshness decay", "newest_article_at": "2026-08-13T13:52:01+00:00", "label": "Early balanced news score", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 72, "events": [{"event": "general", "label": "Market update", "weight": 4.26, "count": 6}, {"event": "earnings", "label": "Earnings", "weight": 4.25, "count": 7}, {"event": "analyst", "label": "Analyst action", "weight": 2.35, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 2, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 4}, "raw_articles": 23, "unique_stories": 19, "duplicates_removed": 4, "relevant_stories": 19, "matched_archive_stories": 19, "current_evidence": 19, "direct_evidence": 19, "eodhd_articles": 4, "archive_articles": 15, "eodhd": {"configured": true, "status": "healthy", "calls_used": 450, "call_budget": 500, "budget_used_pct": 90.0, "requests_made": 90, "last_success_at": "2026-08-13T18:01:20.695134+00:00", "newest_seen_at": "2026-08-13T17:51:50+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3123, "unmapped_mentions": 1847}, "status": "healthy", "durable_evidence_used": true, "durable_collected_at": "2026-08-13T14:35:51.402860+00:00", "durable_newest_article_at": "2026-08-13T13:52:01+00:00", "durable_story_count": 19}}, "market_context": {"has_market_context": true, "latest_close": 207.94, "latest_week": "2026-08-07", "one_week_move": 2.5, "four_week_move": 4.4, "twelve_week_move": 7.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.461741, "market_dynamics_buy_signal": false, "relative_strength": 2.935661, "fair_value_gap": 10.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 54.1488, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.5% over one week, +4.4% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Early company-news score", "tone": "neutral", "classification": "provisional", "summary": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.", "confidence": 36, "badges": ["Provisional evidence"], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 4}, {"label": "MarketWatch", "count": 2}, {"label": "MT Newswires", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "www.marketscreener.com", "count": 1}, {"label": "Motley Fool", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Investing.com Canada", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 19}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 7}, {"label": "Market update", "count": 6}, {"label": "Analyst action", "count": 4}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Early balanced news score"}, {"label": "Evidence confidence", "value": "36/100", "tone": "neutral", "text": "5.47 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Early company-news score", "tone": "neutral", "text": "Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "72/100 evidence concentration around this catalyst."}, {"label": "Company focus", "value": "19", "tone": "positive", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "12/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+2.5% over one week, +4.4% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation"}], "updated_at": "2026-08-13T14:35:51.402860+00:00", "detail_intelligence": {"headline": "Early balanced news score", "summary": "19 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.", "status": "provisional", "metrics": [{"label": "News score", "value": 57, "display": "57", "tone": "neutral", "note": "Early balanced news score"}, {"label": "Confidence", "value": 36, "display": "36", "tone": "neutral", "note": "thin evidence"}, {"label": "Company news", "value": 100, "display": "100%", "tone": "positive", "note": "19 company stories"}, {"label": "Story agreement", "value": 88, "display": "88", "tone": "positive", "note": "12/100 difference"}], "confidence_drivers": [{"label": "Amount of evidence", "value": 13, "note": "0.654 after freshness weighting"}, {"label": "Source breadth", "value": 100, "note": "13 independent publishers"}, {"label": "Company relevance", "value": 100, "note": "share tied directly to this company"}, {"label": "Freshness", "value": 64, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 88, "note": "how closely stories agree"}, {"label": "Publisher mix", "value": 40, "note": "less reliance on one publisher"}], "freshness": 64, "source_independence": 40, "timeline": [{"date": "2026-07-15", "label": "15 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-16", "label": "16 Jul", "count": 0, "score": null, "tone": "neutral", "x": 73.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-17", "label": "17 Jul", "count": 1, "score": 57, "tone": "neutral", "x": 105.2, "y": 122.3, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-18", "label": "18 Jul", "count": 0, "score": null, "tone": "neutral", "x": 136.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-19", "label": "19 Jul", "count": 0, "score": null, "tone": "neutral", "x": 168.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-20", "label": "20 Jul", "count": 1, "score": 50, "tone": "neutral", "x": 199.9, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-21", "label": "21 Jul", "count": 0, "score": null, "tone": "neutral", "x": 231.5, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-22", "label": "22 Jul", "count": 1, "score": 43, "tone": "neutral", "x": 263.1, "y": 147.7, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-23", "label": "23 Jul", "count": 1, "score": 50, "tone": "neutral", "x": 294.7, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 326.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 1, "score": 50, "tone": "neutral", "x": 357.9, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 389.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 421.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 1, "score": 50, "tone": "neutral", "x": 452.6, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 2, "score": 52, "tone": "neutral", "x": 484.2, "y": 131.4, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 1, "score": 50, "tone": "neutral", "x": 515.8, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 1, "score": 75, "tone": "positive", "x": 547.4, "y": 89.5, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 579.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 610.6, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 642.1, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 673.7, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 705.3, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 736.9, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 1, "score": 70, "tone": "positive", "x": 768.5, "y": 98.6, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 1, "score": 50, "tone": "neutral", "x": 800.1, "y": 135.0, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 831.7, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 1, "score": 43, "tone": "neutral", "x": 863.2, "y": 147.7, "volume_height": 26.0, "volume_y": 240.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 2, "score": 60, "tone": "positive", "x": 894.8, "y": 116.8, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 926.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 1, "score": 79, "tone": "positive", "x": 958.0, "y": 82.2, "volume_height": 26.0, "volume_y": 240.0}], "timeline_points": "105.2,122.3 199.9,135.0 263.1,147.7 294.7,135.0 357.9,135.0 452.6,135.0 484.2,131.4 515.8,135.0 547.4,89.5 610.6,135.0 642.1,135.0 673.7,135.0 768.5,98.6 800.1,135.0 863.2,147.7 894.8,116.8 958.0,82.2", "timeline_has_signal": true, "timeline_start": "15 Jul", "timeline_mid": "30 Jul", "timeline_end": "13 Aug", "momentum": {"label": "Tentative improvement", "tone": "neutral", "recent_score": 70, "prior_score": 59, "delta": 11, "recent_count": 3, "prior_count": 3, "volume_delta": 0, "reliable": false, "reliability_note": "Thin comparison; direction is not yet confirmed"}, "freshness_buckets": [{"label": "Last 24 hours", "count": 1, "share": 5}, {"label": "1 to 3 days", "count": 2, "share": 11}, {"label": "4 to 7 days", "count": 3, "share": 16}, {"label": "8 to 14 days", "count": 4, "share": 21}, {"label": "15 to 21 days", "count": 6, "share": 32}, {"label": "22 to 30 days", "count": 3, "share": 16}], "source_profile": [{"label": "finance.yahoo.com", "count": 4, "share": 21, "score": 70, "tone": "positive"}, {"label": "TradingView", "count": 2, "share": 11, "score": 53, "tone": "neutral"}, {"label": "MarketWatch", "count": 2, "share": 11, "score": 50, "tone": "neutral"}, {"label": "MT Newswires", "count": 2, "share": 11, "score": 50, "tone": "neutral"}, {"label": "Simply Wall St", "count": 1, "share": 5, "score": 75, "tone": "positive"}, {"label": "www.marketscreener.com", "count": 1, "share": 5, "score": 43, "tone": "neutral"}, {"label": "Zacks", "count": 1, "share": 5, "score": 43, "tone": "neutral"}], "event_profile": [{"label": "Earnings", "count": 7, "share": 37, "score": 64, "tone": "positive"}, {"label": "Market update", "count": 6, "share": 32, "score": 52, "tone": "neutral"}, {"label": "Analyst action", "count": 4, "share": 21, "score": 73, "tone": "positive"}, {"label": "Regulatory and legal", "count": 1, "share": 5, "score": 62, "tone": "positive"}, {"label": "Deals and strategy", "count": 1, "share": 5, "score": 56, "tone": "neutral"}], "topics": [{"label": "Earnings", "count": 2, "share": 11}, {"label": "Clinical Trials", "count": 2, "share": 11}, {"label": "Biotech", "count": 2, "share": 11}, {"label": "BIOTECH", "count": 2, "share": 11}, {"label": "Price Target", "count": 1, "share": 5}, {"label": "Pharmaceuticals", "count": 1, "share": 5}, {"label": "Pharma", "count": 1, "share": 5}, {"label": "PHARMACEUTICALS", "count": 1, "share": 5}, {"label": "Fda Approval", "count": 1, "share": 5}, {"label": "FDA-APPROVAL", "count": 1, "share": 5}], "supporting": [{"label": "Direct evidence", "text": "19 current stories are mapped specifically to BIIB."}, {"label": "Source breadth", "text": "The read spans 13 publishers rather than depending on one outlet."}], "tempering": [{"label": "Too little evidence", "text": "The stories agree, but freshness-weighted evidence is only 0.654."}], "supporting_heading": "What supports the score", "tempering_heading": "What limits the score", "latest_observation": {"title": "Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation", "summary": "Investing.com -- Wolfe Research upgraded two major pharmaceutical companies to Outperform on Thursday, citing stronger growth prospects, attractive valuations and a series of upcoming clinical catalysts. For Biogen, Wolfe raised its rating from Peer Perform and set a $300 price target, arguing that the company's late-stage pipeline offers significant upside that is not fully reflected in current valuations. The firm highlighted litifilimab and felzartamab as key assets, with clinical readouts expected over the coming year. Wolfe said litifilimab could become the first biologic approved for cut", "url": "https://finance.yahoo.com/healthcare/articles/wolfe-research-upgrades-biogen-abbvie-135201210.html", "source_link": "https://finance.yahoo.com/healthcare/articles/wolfe-research-upgrades-biogen-abbvie-135201210.html", "source_link_is_lookup": false, "source_name": "finance.yahoo.com", "published_at": "2026-08-13T13:52:01+00:00", "published_display": "13 Aug 2026 13:52", "source_kind": "aggregator", "sentiment": "positive", "sentiment_pct": 79, "tone_signals": ["Operating growth", "Growth forecast", "Positive valuation view"], "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.211565, "evidence_share": 32.4, "evidence_share_display": "32.4", "freshness_pct": 95.9, "age_days": 0.2, "influence_label": "High", "duplicate_count": 3, "topics": ["Balance Sheet", "Clinical Trials", "Earnings", "Earnings Growth", "Pharma", "Price Target"], "evidence_basis": "", "score_included": true}, "article_count": 19, "updated_at": "2026-08-13T14:35:51.402860+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 123.2, "label": "13 Feb 2026", "close": 196.52, "index": 100.0}, {"x": 78.4, "y": 138.6, "label": "20 Feb 2026", "close": 192.03, "index": 97.7}, {"x": 114.9, "y": 139.4, "label": "27 Feb 2026", "close": 191.82, "index": 97.6}, {"x": 151.3, "y": 163.3, "label": "06 Mar 2026", "close": 184.87, "index": 94.1}, {"x": 187.7, "y": 174.7, "label": "13 Mar 2026", "close": 181.55, "index": 92.4}, {"x": 224.2, "y": 175.0, "label": "20 Mar 2026", "close": 181.46, "index": 92.3}, {"x": 260.6, "y": 166.8, "label": "27 Mar 2026", "close": 183.84, "index": 93.5}, {"x": 297.0, "y": 189.2, "label": "03 Apr 2026", "close": 177.34, "index": 90.2}, {"x": 333.5, "y": 204.2, "label": "10 Apr 2026", "close": 172.97, "index": 88.0}, {"x": 369.9, "y": 189.1, "label": "17 Apr 2026", "close": 177.35, "index": 90.2}, {"x": 406.3, "y": 165.0, "label": "24 Apr 2026", "close": 184.38, "index": 93.8}, {"x": 442.8, "y": 155.7, "label": "01 May 2026", "close": 187.06, "index": 95.2}, {"x": 479.2, "y": 133.8, "label": "08 May 2026", "close": 193.45, "index": 98.4}, {"x": 515.6, "y": 135.5, "label": "15 May 2026", "close": 192.95, "index": 98.2}, {"x": 552.0, "y": 132.7, "label": "22 May 2026", "close": 193.76, "index": 98.6}, {"x": 588.5, "y": 125.0, "label": "29 May 2026", "close": 196.0, "index": 99.7}, {"x": 624.9, "y": 127.3, "label": "05 Jun 2026", "close": 195.34, "index": 99.4}, {"x": 661.3, "y": 111.1, "label": "12 Jun 2026", "close": 200.05, "index": 101.8}, {"x": 697.8, "y": 123.0, "label": "19 Jun 2026", "close": 196.58, "index": 100.0}, {"x": 734.2, "y": 56.1, "label": "26 Jun 2026", "close": 216.03, "index": 109.9}, {"x": 770.6, "y": 55.8, "label": "03 Jul 2026", "close": 216.12, "index": 110.0}, {"x": 807.1, "y": 114.2, "label": "10 Jul 2026", "close": 199.15, "index": 101.3}, {"x": 843.5, "y": 90.6, "label": "17 Jul 2026", "close": 205.99, "index": 104.8}, {"x": 879.9, "y": 103.7, "label": "24 Jul 2026", "close": 202.19, "index": 102.9}, {"x": 916.4, "y": 101.1, "label": "31 Jul 2026", "close": 202.95, "index": 103.3}, {"x": 952.8, "y": 83.9, "label": "07 Aug 2026", "close": 207.94, "index": 105.8}], "sentiment_points": [{"at": "2026-06-19T23:59:59.999Z", "date": "2026-06-19", "label": "19 Jun 2026", "score": 49, "tone": "neutral", "raw_score": 46, "confidence": 29, "stories": 3, "close": 196.58, "price_change": -1.7, "x": 703.0, "y": 131.8, "show_label": true, "label_y": 121.80000000000001}, {"at": "2026-06-26T23:59:59.999Z", "date": "2026-06-26", "label": "26 Jun 2026", "score": 51, "tone": "neutral", "raw_score": 53, "confidence": 29, "stories": 11, "close": 216.03, "price_change": 9.9, "x": 739.4, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-07-03T23:59:59.999Z", "date": "2026-07-03", "label": "03 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 52, "confidence": 27, "stories": 18, "close": 216.12, "price_change": 0.0, "x": 775.8, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-07-10T23:59:59.999Z", "date": "2026-07-10", "label": "10 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 51, "confidence": 26, "stories": 24, "close": 199.15, "price_change": -7.9, "x": 812.3, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "label": "17 Jul 2026", "score": 51, "tone": "neutral", "raw_score": 54, "confidence": 26, "stories": 25, "close": 205.99, "price_change": 3.4, "x": 848.7, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "label": "24 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 47, "confidence": 26, "stories": 20, "close": 202.19, "price_change": -1.8, "x": 885.1, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "label": "31 Jul 2026", "score": 54, "tone": "neutral", "raw_score": 62, "confidence": 32, "stories": 18, "close": 202.95, "price_change": 0.4, "x": 921.6, "y": 122.6, "show_label": true, "label_y": 112.6}, {"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 53, "tone": "neutral", "raw_score": 61, "confidence": 30, "stories": 16, "close": 207.94, "price_change": 2.5, "x": 958.0, "y": 124.5, "show_label": true, "label_y": 114.5}], "price_path": "42.0,123.2 78.4,138.6 114.9,139.4 151.3,163.3 187.7,174.7 224.2,175.0 260.6,166.8 297.0,189.2 333.5,204.2 369.9,189.1 406.3,165.0 442.8,155.7 479.2,133.8 515.6,135.5 552.0,132.7 588.5,125.0 624.9,127.3 661.3,111.1 697.8,123.0 734.2,56.1 770.6,55.8 807.1,114.2 843.5,90.6 879.9,103.7 916.4,101.1 952.8,83.9", "sentiment_path": "703.0,131.8 739.4,128.2 775.8,130.0 812.3,130.0 848.7,128.2 885.1,130.0 921.6,122.6 958.0,124.5", "score_version": "evidence-v7", "price_change": 5.8, "sentiment_change": 4, "recent_pairs": [{"at": "2026-08-07T23:59:59.999Z", "date": "2026-08-07", "label": "07 Aug 2026", "score": 53, "tone": "neutral", "raw_score": 61, "confidence": 30, "stories": 16, "close": 207.94, "price_change": 2.5, "x": 958.0, "y": 124.5, "show_label": true, "label_y": 114.5}, {"at": "2026-07-31T23:59:59.999Z", "date": "2026-07-31", "label": "31 Jul 2026", "score": 54, "tone": "neutral", "raw_score": 62, "confidence": 32, "stories": 18, "close": 202.95, "price_change": 0.4, "x": 921.6, "y": 122.6, "show_label": true, "label_y": 112.6}, {"at": "2026-07-24T23:59:59.999Z", "date": "2026-07-24", "label": "24 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 47, "confidence": 26, "stories": 20, "close": 202.19, "price_change": -1.8, "x": 885.1, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-17T23:59:59.999Z", "date": "2026-07-17", "label": "17 Jul 2026", "score": 51, "tone": "neutral", "raw_score": 54, "confidence": 26, "stories": 25, "close": 205.99, "price_change": 3.4, "x": 848.7, "y": 128.2, "show_label": true, "label_y": 118.19999999999999}, {"at": "2026-07-10T23:59:59.999Z", "date": "2026-07-10", "label": "10 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 51, "confidence": 26, "stories": 24, "close": 199.15, "price_change": -7.9, "x": 812.3, "y": 130.0, "show_label": false, "label_y": 120.0}, {"at": "2026-07-03T23:59:59.999Z", "date": "2026-07-03", "label": "03 Jul 2026", "score": 50, "tone": "neutral", "raw_score": 52, "confidence": 27, "stories": 18, "close": 216.12, "price_change": 0.0, "x": 775.8, "y": 130.0, "show_label": true, "label_y": 120.0}, {"at": "2026-06-26T23:59:59.999Z", "date": "2026-06-26", "label": "26 Jun 2026", "score": 51, "tone": "neutral", "raw_score": 53, "confidence": 29, "stories": 11, "close": 216.03, "price_change": 9.9, "x": 739.4, "y": 128.2, "show_label": false, "label_y": 118.19999999999999}, {"at": "2026-06-19T23:59:59.999Z", "date": "2026-06-19", "label": "19 Jun 2026", "score": 49, "tone": "neutral", "raw_score": 46, "confidence": 29, "stories": 3, "close": 196.58, "price_change": -1.7, "x": 703.0, "y": 131.8, "show_label": true, "label_y": 121.80000000000001}], "reconstructed": true, "latest_close": 207.94, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug", "live_score_version": "evidence-v7", "comparable_to_live": true}, "sentiment_history": [{"label": "18 Jun 23:59", "short_label": "18 Jun", "collected_at": "2026-06-18T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "19 Jun 23:59", "short_label": "19 Jun", "collected_at": "2026-06-19T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": -1, "score_change_display": "-1", "confidence_change": 1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 3, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "21 Jun 23:59", "short_label": "21 Jun", "collected_at": "2026-06-21T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 2, "score_change_display": "+2", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 4, "articles": 5, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "24 Jun 23:59", "short_label": "24 Jun", "collected_at": "2026-06-24T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 8, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "25 Jun 23:59", "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 9, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "26 Jun 23:59", "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 11, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "27 Jun 23:59", "short_label": "27 Jun", "collected_at": "2026-06-27T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 12, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "28 Jun 23:59", "short_label": "28 Jun", "collected_at": "2026-06-28T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 13, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "29 Jun 23:59", "short_label": "29 Jun", "collected_at": "2026-06-29T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 15, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "30 Jun 23:59", "short_label": "30 Jun", "collected_at": "2026-06-30T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 16, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "03 Jul 23:59", "short_label": "03 Jul", "collected_at": "2026-07-03T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 18, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "05 Jul 23:59", "short_label": "05 Jul", "collected_at": "2026-07-05T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 19, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "06 Jul 23:59", "short_label": "06 Jul", "collected_at": "2026-07-06T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 20, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "07 Jul 23:59", "short_label": "07 Jul", "collected_at": "2026-07-07T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 21, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "08 Jul 23:59", "short_label": "08 Jul", "collected_at": "2026-07-08T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "09 Jul 23:59", "short_label": "09 Jul", "collected_at": "2026-07-09T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 23, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "10 Jul 23:59", "short_label": "10 Jul", "collected_at": "2026-07-10T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 24, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "17 Jul 23:59", "short_label": "17 Jul", "collected_at": "2026-07-17T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 25, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "20 Jul 23:59", "short_label": "20 Jul", "collected_at": "2026-07-20T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": -2, "tone": "neutral", "height": 4, "articles": 23, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "22 Jul 23:59", "short_label": "22 Jul", "collected_at": "2026-07-22T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": -1, "score_change_display": "-1", "confidence_change": 4, "article_change": -2, "tone": "neutral", "height": 4, "articles": 21, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "23 Jul 23:59", "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "25 Jul 23:59", "short_label": "25 Jul", "collected_at": "2026-07-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 1, "score_change_display": "+1", "confidence_change": -1, "article_change": -2, "tone": "neutral", "height": 4, "articles": 20, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "28 Jul 23:59", "short_label": "28 Jul", "collected_at": "2026-07-28T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": -3, "tone": "neutral", "height": 4, "articles": 17, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 4, "article_change": 0, "tone": "neutral", "height": 4, "articles": 17, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "30 Jul 23:59", "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 17, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "31 Jul 23:59", "short_label": "31 Jul", "collected_at": "2026-07-31T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 3, "score_change_display": "+3", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 8, "articles": 18, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": -1, "tone": "neutral", "height": 6, "articles": 17, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 18, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "04 Aug 23:59", "short_label": "04 Aug", "collected_at": "2026-08-04T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 18, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": -2, "tone": "neutral", "height": 6, "articles": 16, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 6, "articles": 16, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 16, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 18, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "13 Aug 18:11", "short_label": "13 Aug", "collected_at": "2026-08-13T18:11:43.486204+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 19, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}], "sentiment_history_insight": {"available": true, "series_version": "evidence-v7", "live_version": "evidence-v7", "comparable_to_live": true, "reconstructed": true, "observations": 35, "span_label": "56 days", "first_score": 50, "latest_score": 52, "net_change": 2, "net_change_display": "+2", "direction": "Broadly stable", "high_score": 54, "low_score": 49, "latest_confidence": 30, "confidence_change": 2, "latest_articles": 19, "article_change": 18, "latest_label": "13 Aug 18:11", "latest_evidence_label": "Provisional", "chart_rows": [{"label": "18 Jun 23:59", "short_label": "18 Jun", "collected_at": "2026-06-18T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": null, "score_change_display": "Start", "confidence_change": null, "article_change": null, "tone": "neutral", "height": 4, "articles": 1, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 42.0, "y": 135.0}, {"label": "19 Jun 23:59", "short_label": "19 Jun", "collected_at": "2026-06-19T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": -1, "score_change_display": "-1", "confidence_change": 1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 3, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 68.9, "y": 136.8}, {"label": "21 Jun 23:59", "short_label": "21 Jun", "collected_at": "2026-06-21T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 2, "score_change_display": "+2", "confidence_change": 0, "article_change": 2, "tone": "neutral", "height": 4, "articles": 5, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 95.9, "y": 133.2}, {"label": "22 Jun 23:59", "short_label": "22 Jun", "collected_at": "2026-06-22T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 6, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 122.8, "y": 133.2}, {"label": "24 Jun 23:59", "short_label": "24 Jun", "collected_at": "2026-06-24T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 8, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 149.8, "y": 135.0}, {"label": "25 Jun 23:59", "short_label": "25 Jun", "collected_at": "2026-06-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 9, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 176.7, "y": 135.0}, {"label": "26 Jun 23:59", "short_label": "26 Jun", "collected_at": "2026-06-26T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 11, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 203.6, "y": 133.2}, {"label": "27 Jun 23:59", "short_label": "27 Jun", "collected_at": "2026-06-27T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -2, "article_change": 1, "tone": "neutral", "height": 4, "articles": 12, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 230.6, "y": 133.2}, {"label": "28 Jun 23:59", "short_label": "28 Jun", "collected_at": "2026-06-28T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 13, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 257.5, "y": 133.2}, {"label": "29 Jun 23:59", "short_label": "29 Jun", "collected_at": "2026-06-29T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": 2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 15, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 284.5, "y": 133.2}, {"label": "30 Jun 23:59", "short_label": "30 Jun", "collected_at": "2026-06-30T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 16, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 311.4, "y": 133.2}, {"label": "03 Jul 23:59", "short_label": "03 Jul", "collected_at": "2026-07-03T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": 2, "tone": "neutral", "height": 4, "articles": 18, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 338.4, "y": 135.0}, {"label": "05 Jul 23:59", "short_label": "05 Jul", "collected_at": "2026-07-05T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -3, "article_change": 1, "tone": "neutral", "height": 4, "articles": 19, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 365.3, "y": 135.0}, {"label": "06 Jul 23:59", "short_label": "06 Jul", "collected_at": "2026-07-06T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 20, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 392.2, "y": 133.2}, {"label": "07 Jul 23:59", "short_label": "07 Jul", "collected_at": "2026-07-07T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 21, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 419.2, "y": 135.0}, {"label": "08 Jul 23:59", "short_label": "08 Jul", "collected_at": "2026-07-08T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 446.1, "y": 135.0}, {"label": "09 Jul 23:59", "short_label": "09 Jul", "collected_at": "2026-07-09T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 23, "confidence": 25, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 473.1, "y": 135.0}, {"label": "10 Jul 23:59", "short_label": "10 Jul", "collected_at": "2026-07-10T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 24, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 500.0, "y": 135.0}, {"label": "17 Jul 23:59", "short_label": "17 Jul", "collected_at": "2026-07-17T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": 1, "score_change_display": "+1", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 25, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 526.9, "y": 133.2}, {"label": "20 Jul 23:59", "short_label": "20 Jul", "collected_at": "2026-07-20T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": -1, "score_change_display": "-1", "confidence_change": -2, "article_change": -2, "tone": "neutral", "height": 4, "articles": 23, "confidence": 24, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 553.9, "y": 135.0}, {"label": "22 Jul 23:59", "short_label": "22 Jul", "collected_at": "2026-07-22T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": -1, "score_change_display": "-1", "confidence_change": 4, "article_change": -2, "tone": "neutral", "height": 4, "articles": 21, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 580.8, "y": 136.8}, {"label": "23 Jul 23:59", "short_label": "23 Jul", "collected_at": "2026-07-23T23:59:59.999999+00:00", "score": 49, "delta": -1, "score_change": 0, "score_change_display": "+0", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 22, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 607.8, "y": 136.8}, {"label": "25 Jul 23:59", "short_label": "25 Jul", "collected_at": "2026-07-25T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 1, "score_change_display": "+1", "confidence_change": -1, "article_change": -2, "tone": "neutral", "height": 4, "articles": 20, "confidence": 27, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 634.7, "y": 135.0}, {"label": "28 Jul 23:59", "short_label": "28 Jul", "collected_at": "2026-07-28T23:59:59.999999+00:00", "score": 50, "delta": 0, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": -3, "tone": "neutral", "height": 4, "articles": 17, "confidence": 26, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 661.6, "y": 135.0}, {"label": "29 Jul 23:59", "short_label": "29 Jul", "collected_at": "2026-07-29T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 2, "score_change_display": "+2", "confidence_change": 4, "article_change": 0, "tone": "neutral", "height": 4, "articles": 17, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 688.6, "y": 131.4}, {"label": "30 Jul 23:59", "short_label": "30 Jul", "collected_at": "2026-07-30T23:59:59.999999+00:00", "score": 51, "delta": 1, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 17, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 715.5, "y": 133.2}, {"label": "31 Jul 23:59", "short_label": "31 Jul", "collected_at": "2026-07-31T23:59:59.999999+00:00", "score": 54, "delta": 4, "score_change": 3, "score_change_display": "+3", "confidence_change": 3, "article_change": 1, "tone": "neutral", "height": 8, "articles": 18, "confidence": 32, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 742.5, "y": 127.7}, {"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": -1, "tone": "neutral", "height": 6, "articles": 17, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 769.4, "y": 129.5}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 18, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 796.4, "y": 131.4}, {"label": "04 Aug 23:59", "short_label": "04 Aug", "collected_at": "2026-08-04T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 18, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 823.3, "y": 131.4}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": -2, "tone": "neutral", "height": 6, "articles": 16, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 850.2, "y": 129.5}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 6, "articles": 16, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 877.2, "y": 129.5}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 16, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 904.1, "y": 131.4}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 18, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 931.1, "y": 131.4}, {"label": "13 Aug 18:11", "short_label": "13 Aug", "collected_at": "2026-08-13T18:11:43.486204+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 19, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true, "x": 958.0, "y": 131.4}], "chart_points": "42.0,135.0 68.9,136.8 95.9,133.2 122.8,133.2 149.8,135.0 176.7,135.0 203.6,133.2 230.6,133.2 257.5,133.2 284.5,133.2 311.4,133.2 338.4,135.0 365.3,135.0 392.2,133.2 419.2,135.0 446.1,135.0 473.1,135.0 500.0,135.0 526.9,133.2 553.9,135.0 580.8,136.8 607.8,136.8 634.7,135.0 661.6,135.0 688.6,131.4 715.5,133.2 742.5,127.7 769.4,129.5 796.4,131.4 823.3,131.4 850.2,129.5 877.2,129.5 904.1,131.4 931.1,131.4 958.0,131.4", "changes": [{"label": "13 Aug 18:11", "short_label": "13 Aug", "collected_at": "2026-08-13T18:11:43.486204+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 1, "tone": "neutral", "height": 4, "articles": 19, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "11 Aug 23:59", "short_label": "11 Aug", "collected_at": "2026-08-11T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 2, "tone": "neutral", "height": 4, "articles": 18, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "10 Aug 23:59", "short_label": "10 Aug", "collected_at": "2026-08-10T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 16, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "08 Aug 23:59", "short_label": "08 Aug", "collected_at": "2026-08-08T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 0, "score_change_display": "+0", "confidence_change": 1, "article_change": 0, "tone": "neutral", "height": 6, "articles": 16, "confidence": 31, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "07 Aug 23:59", "short_label": "07 Aug", "collected_at": "2026-08-07T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": 1, "score_change_display": "+1", "confidence_change": 2, "article_change": -2, "tone": "neutral", "height": 6, "articles": 16, "confidence": 30, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "04 Aug 23:59", "short_label": "04 Aug", "collected_at": "2026-08-04T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": 0, "score_change_display": "+0", "confidence_change": -1, "article_change": 0, "tone": "neutral", "height": 4, "articles": 18, "confidence": 28, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "03 Aug 23:59", "short_label": "03 Aug", "collected_at": "2026-08-03T23:59:59.999999+00:00", "score": 52, "delta": 2, "score_change": -1, "score_change_display": "-1", "confidence_change": 0, "article_change": 1, "tone": "neutral", "height": 4, "articles": 18, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}, {"label": "02 Aug 23:59", "short_label": "02 Aug", "collected_at": "2026-08-02T23:59:59.999999+00:00", "score": 53, "delta": 3, "score_change": -1, "score_change_display": "-1", "confidence_change": -3, "article_change": -1, "tone": "neutral", "height": 6, "articles": 17, "confidence": 29, "evidence_status": "provisional", "evidence_label": "Provisional", "score_version": "evidence-v7", "reconstructed": true}]}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}